Real-time quantification of human telomerase reverse transcriptase mRNA in the plasma of patients with prostate cancer

Annals of the New York Academy of Sciences

Volumn 1075, Issue , 2006, Pages 204-210

  Dasi F ^a   Martinez Rodes P ^a   March, J A ^b   Santamaria J ^b   Martinez Javaloyas J M ^b   Gil, M ^b   Aliño, Salvador F ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

hTERT; Plasma; Prostate cancer; RNA; serum

Indexed keywords

MESSENGER RNA; MOLECULAR MARKER; PROSTATE SPECIFIC ANTIGEN; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR MARKER;

CANCER DIAGNOSIS; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENZYME BLOOD LEVEL; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PROSTATE CANCER; PROSTATITIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

EID: 33749573193     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1368.028     Document Type: Conference Paper

References (14)

1. JEMAL, A. et al. 2003. Cancer statistics, 2003. CA. Cancer J. Clin. 53: 5-26.
2. BOTCHKINA, G.I. et al. 2005. Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity. Clin. Cancer Res. 11: 3243-3249.
3. GOHAGEN, J.K. et al. 1994. Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening of the National Cancer Institute. J. Urol. 152: 1905-1909.
4. PANNEK, J. & A.W. PARTIN. 1997. Prostate-specific antigen: what's new in 1997. Oncology 11: 1273-1278.
5. WANG, M.D. et al. 2001. Detection of telomerase activity in prostatic fluid specimens. Urol. Oncol. 6: 4-9.
6. TRICOLI, J.V et al. 2004. Detection of prostate cancer and predicting progression: current and future diagnostic markers. Clin. Cancer Res. 10: 3943-3953.
7. MIURA, N. et al. 2005. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma. Clin. Cancer Res. 11: 3205-3209.
8. NOVAKOVIC, S. et al. 2004. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer. Oncol. Rep. 11: 245-252.
9. KOPRESKI, M.S. 1999. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin. Cancer Res. 5: 1961-1965.
10. CHEN, X. et al. 2000. Telomerase RNA as detection marker in the serum of breast cancer patients. Clin. Cancer. Res. 6: 3823-3826.
11. DASI, F. et al. 2001. Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: a single blood test to monitor disease in patients. Lab. Invest. 81: 767-769.
12. LLEDO, S. et al. 2004. Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer. Color Dis. 6: 236-242.
13. DE KOK, J.B. et al. 2002. DD3PCA3, a very sensitive and specific marker to detect prostate tumors. Cancer Res. 62: 2695-2698.
14. CATALONA, W.J. et al. 1991. Measurement of prostate specific antigen in serum as screening test for prostate cancer. N. Engl. J. Med. 324: 1156-1161.